STAA - STAAR Surgical Company logo

STAA

STAAR Surgical Company

STAAR Surgical Company designs, manufactures, and sells phakic implantable lenses and delivery systems for vision correction. Its products, including the EVO ICL family, target myopia, hyperopia, astigmatism, and presbyopia, serving healthcare providers globally.

โš•๏ธ Healthcare NASDAQ Listed 1983 $ USD
$1,000 invested 30 years ago โ†’$1,955today

Score Overview

1 Year
Score
Net Growth73.86%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth21.27%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.6
Net Growth-176.45%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth25.99%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-73.39%
Net Trend60%
Net Income Consistency
Rev Growth252.26%
Rev Trend80%
Revenue Consistency
20 Years
Score4.7
Net Growth-39.80%
Net Trend55%
Net Income Consistency
Rev Growth415.93%
Rev Trend85%
Revenue Consistency
30 Years
Score
Net Growth-404.80%
Net Trend50%
Net Income Consistency
Rev Growth6x
Rev Trend77%
Revenue Consistency
All Time
Score
Net Growth-453.45%
Net Trend50%
Net Income Consistency
Rev Growth42x
Rev Trend74%
Revenue Consistency

See the full market ranking โ†’

STAAR Surgical Company fundamental performance

Between 2015 and 2025, revenue grew from $ 77M to $ 239M and net income went from -$ 6M to -$ 80M. Revenue increased in 8 of those 10 years; net income in 6.

Between 2005 and 2025, revenue grew from $ 51M to $ 239M and net income went from -$ 11M to -$ 80M. Revenue increased in 17 of those 20 years; net income in 11.

STAAR Surgical Company currently holds a 20-year HDB Score of 4.7 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 25.41โ€”
1 Year2025-08-12
$ 27.39-7.23%
5 Years2021-08-12
$ 136.29-81.36%
10 Years2016-08-12
$ 8.89185.83%
20 Years2006-08-11
$ 6.85270.95%
30 Years1996-08-12
$ 13.0095.46%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 290M-$ 21M$ 163M
2025$ 239M-$ 80M$ 187M
2024$ 313M-$ 20M$ 230M
2023$ 322M$ 21M$ 220M
2022$ 284M$ 39M$ 211M
2021$ 230M$ 27M$ 199M
2020$ 163M$ 5M$ 152M
2019$ 150M$ 14M$ 119M
2018$ 123M$ 4M$ 103M
2017$ 90M-$ 2M$ 18M
2016$ 82M-$ 12M$ 13M
2015$ 77M-$ 6M$ 13M
2014$ 74M-$ 8M$ 13M
2013$ 72M$ 398K$ 22M
2012$ 63M-$ 1M$ 21M
2011$ 62M$ 1M$ 16M
2010$ 54M$ 53K$ 9M
2009$ 75M-$ 6M$ 6M
2008$ 74M-$ 23M$ 5M
2007$ 59M-$ 15M$ 11M
2006$ 56M-$ 15M$ 7M
2005$ 51M-$ 11M$ 12M
2004$ 51M-$ 11M$ 9M
2003$ 50M-$ 8M$ 7M
2002$ 48M-$ 17M$ 1M
2001$ 50M-$ 14M$ 853K
2000$ 53M-$ 18M$ 6M
1999$ 59M$ 2M$ 3M
1998$ 54M$ 2M$ 4M
1997$ 42M$ 7M$ 6M
1996$ 42M$ 6M$ 6M
1995$ 34M$ 7M$ 3M
1994$ 27M$ 8M$ 3M
1993$ 20M$ 2M$ 1M
1992$ 10M-$ 5M$ 1M
1991$ 4M-$ 11M$ 2M
1990$ 4M$ 3M$ 700K
1989$ 4M-$ 4M
1988$ 6M-$ 3M$ 100K

Explore beyond STAA

You're looking at STAAR Surgical Company. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies